NCT07038473Recruiting
Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 3500 (estimated)
- First submitted
- 6 Jun 2025
- Start date
- 17 Dec 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Sanofi
- Diseases
- Type 1 diabetes
- NCT number
- NCT07038473
What you commit to
- Study type: Interventional
- Planned participants: 3500
- From 17 Dec 2025 to the primary completion date, 30 Jun 2027
- 7 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have a previous history of being treated with insulin
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Other illness
- Known diabetes of any kind (type 1, type 2, Maturity Onset Diabetes of the Young - MODY)
Other
- Already developed clinical overt T1D
Who the study is looking for
- Children and adolescents, age 1.5 years to 18 years
- First degree relatives of T1D probands
- Parent or legal guardian signing an informed consent
Age in the registry: 18 months to 18 years · Sex: All · Accepts healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sheikh Shakhbout Medical City - Site Number: 06 Coordinator of this site? Confirm its status | Abu Dhabi | United Arab Emirates | Recruiting |
| Sheikh Khalifa Medical City - Site Number: 07 Coordinator of this site? Confirm its status | Abu Dhabi | United Arab Emirates | Recruiting |
| Dasman Diabetes Institute - Site Number: 08 Coordinator of this site? Confirm its status | Kuwait City | Kuwait | Recruiting |
| Imam Abdulrahman Bin Faisal University - Site Number: 05 Coordinator of this site? Confirm its status | Dammam | Saudi Arabia | Recruiting |
| King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01 Coordinator of this site? Confirm its status | Jeddah | Saudi Arabia | Recruiting |
| King Faisal Specialist Hospital & Research Centre - Site Number: 02 Coordinator of this site? Confirm its status | Riyadh | Saudi Arabia | Recruiting |
| King Fahd Medical City - Site Number: 03 Coordinator of this site? Confirm its status | Riyadh | Saudi Arabia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.